Hey everyone! It’s great to be back. I got way behind with things after slipping and falling and dislocating my shoulder at the end of January, but I hope to be back to blogging regularly now. Many of you may remember the drug torcetrapib, aimed at increasing HDL-cholesterol. It failed miserably, and killed a lot …
Blood Lipids
The Total-to-HDL Cholesterol Ratio — What Does It Mean?
Someone recently forwarded to me two references that a high-level New Zealand professor had used to support recommendations against saturated fat and coconut oil. The references did not support the conclusion at all, but they did provide some interesting insight about the importance of the total-to-HDL cholesterol ratio and its dietary implications. Both of the …
JUPITER Trial Emphasizes the Role of Oxidative Degeneration in Atherosclerosis
by Chris Masterjohn The most recent widely publicized trial using the cholesterol-lowering statin drugs, the JUPITER trial, has been enthusiastically hailed as a justification for the expansion of these expensive drugs from people with high cholesterol levels to those who have low-grade inflammation but normal cholesterol. The study hardly justifies this enthusiasm. It does, however, …
My Brief Appearance on YouTube
Aaron Lucich interviewed me at the November 2008, Wise Traditions San Francisco conference of the Weston A. Price Foundation. A brief clip from this interview appears on the following video, available free on YouTube: